Respiratory care startup Telesair raises $22M and extra digital well being fundings

Telesair, a medical gadget firm growing hospital-to-home merchandise for respiratory care, introduced it had raised $22 million in Sequence A funding.

The spherical was led by Pasaca Capital with participation from Honeywell Ventures, ZhenCheng Capital, Shangbay Capital, System of Tomorrow Capital, Berkeley Catalyst Fund and Ultrastar Ventures LLC. 

The funding can be used to commercialize its Bonhawa Respiratory Humidifier, designed to be used within the ICU, and help the event of a brand new product that goals to assist sufferers go away the hospital extra rapidly and keep at house safely.

“Honeywell is aligned with Telesair’s mission to enhance lives by innovation in digital healthcare,” Patrick Hogan, managing director of Honeywell Ventures, mentioned in a press release. “We’re impressed with their mission and expertise roadmap, and we’re excited to collaborate with them in essential areas similar to superior sensing and distant affected person monitoring, enabled by synthetic intelligence and machine studying.”

ModifyHealth, which delivers medically tailor-made meals and provides digital help from dietitians, raised $10 million in a Sequence B funding spherical led by RC Capital with participation from present investor Nashville Capital Community.

The startup works with sufferers with power situations like Sort 2 diabetes, hypertension, kidney illness, weight problems and irritable bowel syndrome. Modify, which raised its $2 million Sequence A in 2020, plans to make use of the funds to help its development and increase its nationwide operations. 

“Eating regimen and life-style play a significant position within the administration of power well being situations and we’re simply scratching the floor on the impression we are able to make. RCC is a good match for ModifyHealth and their strategic help, healthcare experience, and shared imaginative and prescient will assist us ship outcomes extra quickly and broadly,” GB Pratt, founder and CEO of ModifyHealth, mentioned in a press release.

Censinet, developer of healthcare cybersecurity software program, scored $9 million in a funding spherical led by MemorialCare Innovation Fund.

Different individuals within the elevate embrace Rex Well being Ventures, Ballad Ventures, LRVHealth, HLM Enterprise Companions, Schooner Capital, Excelerate Well being Ventures and Cedars Sinai. Censinet mentioned the spherical brings its complete funding pot to greater than $22 million. 

“With the variety of breaches escalating and ransomware now a direct risk to affected person security, the necessity for the healthcare trade to remodel cyber danger administration has by no means been extra pressing. Censinet’s distinctive danger alternate allows suppliers, payers and distributors to collaboratively handle third occasion and enterprise danger, constantly bettering danger posture in real-time and strengthening cybersecurity throughout all healthcare organizations,” Ed Gaudet, the corporate’s CEO and founder, mentioned in a press release.

Dutch startup Lapsi Well being raised $3.7 million in a seed funding spherical led by Sahir Ali of Modi Ventures.

The corporate is growing digital biomarkers utilizing auscultatory sound, or inner physique sounds from the guts, lungs and stomach. Lapsi will use the capital to proceed to develop their instruments, undergo the FDA and increase into the U.S. market. 

CARI Well being, which is growing a wearable sensor for treatment administration, raised $2.3 million in seed funding. 

The spherical was led by the San Diego Angel Convention (SDAC) with participation from NuFund Enterprise Group, Cove Fund, Chemical Angel Fund, Medical Units of Tomorrow and angel traders. 

The startup is making a sensor worn on the pores and skin that permits for distant treatment monitoring. If treatment ranges fall outdoors of set tips, sufferers, relations and suppliers can obtain alerts.

The capital will go towards finishing its first human medical research, increasing its mental property portfolio and planning for a regulatory submission with the FDA. CARI will first concentrate on monitoring medicines for opioid use dysfunction (MOUD).

“We’re passionate concerning the potential to make an impression and construct one thing greater than ourselves,” founder and CEO Patrik Schmidle mentioned in a press release. “Wearable distant monitoring can be life-changing for a whole bunch of 1000’s of MOUD sufferers, who below as we speak’s customary of care have to point out up virtually each day for clinic visits, particularly at first of remedy.”